Illinois Rep. Cassidy’s prescription monitoring exemption bill passes House and Senate

Passed bill authored by State Rep. Kelly M. Cassidy aims to remove specific drugs from the state’s prescription monitoring system and require the deletion of related records, according to the Illinois General Assembly.

In the House, 68 Democrats voted in favor of the bill, while 37 Republicans opposed it.

Meanwhile, in the Senate, 39 Democrats voted in favor of the bill, while 19 Republicans voted against it.

Cassidy introduced the bill in the Illinois House on Feb. 3, 2026 during the 104th session.

The legislation, known as HB4834, was passed on May 20, 2026 during the general assembly session 104.

According to the Illinois General Assembly site, the legislature summarized the bill’s official text as follows: “Amends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.”

The following is our breakdown, based on the actual bill text, and may include interpretation to clarify its provisions.

In essence, this bill changes the Illinois Prescription Monitoring Program so that it no longer applies to testosterone, mifepristone, misoprostol, GnRH analogues or estrogen, meaning prescriptions for those drugs are not tracked in the statewide database. It requires the Department of Human Services to purge all existing Prescription Monitoring Program records on prescribing or dispensing testosterone, including data in any central repository or database, by Jan. 1, 2027, and to prevent any new testosterone records from being created after that date. The department must update and adopt rules to carry out these changes by Jan. 1, 2027. The bill takes effect immediately.

The bill was sponsored by Sen. Adriane Johnson (Democrat-30th District), Rep. Amy Briel (Democrat-76th District), and Rep. Anna Moeller (Democrat-43rd District), along with 28 other sponsors.

Bills in Illinois follow a multi-step legislative process, beginning with introduction in either the House or Senate, followed by committee review, floor debates, and votes in both chambers before reaching the governor for approval or veto. The General Assembly operates on a biennial schedule, and while typically thousands of bills are introduced each session, only a fraction successfully pass through the process to become law.

You can read more about bills and other measures here.

Cassidy, a Democrat, was elected to the Illinois State House in 2011 to represent the state’s 14th House District, replacing previous state representative Harry Osterman.

Lawmakers listed as “Not Voting” were present for the vote but did not cast a vote. Those marked as having an “Excused Absence” were not present and formally provided a reason for their absence, which was accepted.